The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity

• Status: Not yet recruiting
• Trial end date: 2023-08-15
• Target enrollment: 0
• Participant gender: All

Summary

The patients between the ages of 35-80 who developed spasticity in the upper extremity after stroke will be included.. Botulinum toxin(BT-A) injection will be applied to the study group(n=16) and placebo injection to the control group(n=15) in addition to conventional rehabilitation and stretching exercises. Evaluations will be made before the treatment, in the 2nd week, and in 3rd month after the treatment. Pain relief will be evaluated with the Visual Analog Scale(VAS) and spasticity assessment will be done with the Modified Ashworth Scale(MAS). The functionality will be evaluated with Fugl Meyer Assessment Scale(FMAS) and Box Block Test(BBT).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sisli Hamidiye Etfal Training and Research Hospital
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A

Criteria

Inclusion Criteria:

• hemiplegia due to a cerebrovascular accident at least 1 month ago

• cognitively competent

• have spasticity of 1 and above according to the Modified Ashworth Scale

• receive at least 3 cubes in the Box Block Test

Exclusion Criteria:

• Patients with upper extremity brachial plexus lesions,

• shoulder subluxation,

• arthritis and joint contracture,

• neglect syndrome,

• cerebellar and brain stem lesions

• those who did not accept the study